What is Liminatus Pharma, Inc. Class A Common Stock's Market Cap?

Liminatus Pharma, Inc. Class A Common Stock's Market Cap is $238.4M, based on as-reported figures from SEC (XBRL) filings.

What is Liminatus Pharma, Inc. Class A Common Stock's Enterprise Value?

Liminatus Pharma, Inc. Class A Common Stock's Enterprise Value is $236.8M, based on as-reported figures from SEC (XBRL) filings.

What is Liminatus Pharma, Inc. Class A Common Stock's EV / EBITDA?

Liminatus Pharma, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Liminatus Pharma, Inc. Class A Common Stock's Net Income (TTM)?

Liminatus Pharma, Inc. Class A Common Stock's Net Income (TTM) is -$12.5M, based on as-reported figures from SEC (XBRL) filings.

What is Liminatus Pharma, Inc. Class A Common Stock's EBITDA?

Liminatus Pharma, Inc. Class A Common Stock's EBITDA is -$4.1M, based on as-reported figures from SEC (XBRL) filings.

What is Liminatus Pharma, Inc. Class A Common Stock's Diluted EPS (TTM)?

Liminatus Pharma, Inc. Class A Common Stock's Diluted EPS (TTM) is -0.19, based on as-reported figures from SEC (XBRL) filings.

What is Liminatus Pharma, Inc. Class A Common Stock's Net Debt?

Liminatus Pharma, Inc. Class A Common Stock's Net Debt is -$1.6M, based on as-reported figures from SEC (XBRL) filings.

Liminatus Pharma, Inc. Class A Common Stock (LIMN) Financial Statements

Liminatus Pharma, Inc. Class A Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG01HVYG120

XNAS · usd

3.55▼ 0.07 (-1.93%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close3.62

Day's Range3.52 – 3.73

52-Week Range0.10 – 5.88

Volume26.0K

Avg Volume21.1M

Share Statistics

Shares Outstanding

Employees1

ExchangeXNAS

Listed2025-05-01

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Liminatus Pharma, Inc. Class A Common Stock (LIMN)

What is Liminatus Pharma, Inc. Class A Common Stock's Market Cap?: Liminatus Pharma, Inc. Class A Common Stock's Market Cap is $238.4M, based on as-reported figures from SEC (XBRL) filings.
What is Liminatus Pharma, Inc. Class A Common Stock's Enterprise Value?: Liminatus Pharma, Inc. Class A Common Stock's Enterprise Value is $236.8M, based on as-reported figures from SEC (XBRL) filings.
What is Liminatus Pharma, Inc. Class A Common Stock's EV / EBITDA?: Liminatus Pharma, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Liminatus Pharma, Inc. Class A Common Stock's Net Income (TTM)?: Liminatus Pharma, Inc. Class A Common Stock's Net Income (TTM) is -$12.5M, based on as-reported figures from SEC (XBRL) filings.
What is Liminatus Pharma, Inc. Class A Common Stock's EBITDA?: Liminatus Pharma, Inc. Class A Common Stock's EBITDA is -$4.1M, based on as-reported figures from SEC (XBRL) filings.
What is Liminatus Pharma, Inc. Class A Common Stock's Diluted EPS (TTM)?: Liminatus Pharma, Inc. Class A Common Stock's Diluted EPS (TTM) is -0.19, based on as-reported figures from SEC (XBRL) filings.
What is Liminatus Pharma, Inc. Class A Common Stock's Net Debt?: Liminatus Pharma, Inc. Class A Common Stock's Net Debt is -$1.6M, based on as-reported figures from SEC (XBRL) filings.